Davis Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
PCM
MWM
MNBTD
LSERS
SOADOR
PFSRSONJ
SBCM
YCM
Davis Capital Management's NEO Position: Q2 2026 in Review
Davis Capital Management opened a new position in NeoGenomics (NEO) in Q2 2026: 7 shares worth $102. The stake represents ﹤0.01% of the portfolio and ranks #1059 among its holdings.
43 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Davis Capital Management held 7 shares of NeoGenomics worth $102 as of Q2 2026.
- NeoGenomics was a new Davis Capital Management position in Q2 2026.
- NeoGenomics made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1059 holding.
- 43 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.